结论：EFH具有一定的抗凝溶栓作用。
Conclusion: EFH has anticoagulant and thrombolytic function.
该文对这些活性物质的抗凝溶栓机制进行综述。
This paper reviews the anticoagulant and thrombolysis mechanism of these anticoagulant proteins.
目的探讨治疗下肢深静脉血栓超声消融术后抗凝溶栓用药方案。
Objective To explore scheme of anticoagulation and thrombolysis after ultrasound ablation for lower limbs deep vein thrombosis (DVT).
结论下肢深静脉血栓形成病例安置下腔静脉滤过器后，行局部大剂量抗凝溶栓治疗安全有效。
ConclusionPlacement of VCF is effective and safe for patients with deep venous thrombosis in lower limbs along with therapy of local anti-coagulation and thrombolysis.
结论：在急性下肢深静脉血栓抗凝溶栓治疗前置入下腔静脉滤器，是预防肺栓塞安全有效的方法。
Conclusion: to prevent pulmonary embolism, it is effective to inferior vena cava filter insertion before the patient with acute DVT is given by thrombolytic therapy.
急性MVT在肠缺血尚未导致透壁性肠坏死、肠穿孔时，抗凝溶栓治疗可行，如有急性腹膜炎时中转手术。
Anti-coagulation and thrombolytic therapy for MVT is feasible when the initial diagnosis is certain and bowel infarction has not let to transmural necrosis and bowel perforation.
溶栓治疗和抗凝治疗可有效改善患者预后。
Thrombolytic therapy and anti-coagulation could effective improve the prognosis of PE patients.
经介入放射局部溶栓和全身抗凝治疗后，颅高压明显降低，神经系统局灶体征减轻。
After the infusion of thrombolytic and systemic anticoagulant therapy, all the neurological symptoms and signs in the patients were alleviated.
及早诊断，行抗凝、溶栓治疗可防止肠坏死的发生。
Early diagnosis and active thrombolysis may help to prevent the intestinal necrosis.
目的探讨溶栓及抗凝治疗急性肺血栓栓塞症(pte)的护理措施。
Objective To explore the nursing of thrombolytic and anticoagulant therapy in acute pulmonary thromboembolism. (PTE).
早期溶栓和抗凝治疗对肾脏功能的恢复有帮助。
Early thrombolytic and anticoagulant therapy is beneficial for the recovery of renal function.
早期抗凝和溶栓治疗对提高患者的生存率有明显的作用。
Early anti-coagulated and thrombosis-dissolved treatment can increase the survival rate of SMVT patients.
目的研究经导管肺动脉局部溶栓加抗凝治疗在急性肺栓塞性肺动脉高压的作用。
Objective To investigate local thrombolysis and anticoagulation by catheter in the treatment of acute thromboembolic pulmonary hypertension.
目的探讨早期溶栓、抗凝预防下肢深静脉血栓形成(DVT)的效果。
Objective To discuss the effect of early anti-coagulation and thrombolytic therapy in preventing DVT.
目前治疗手段主要包括溶栓、抗凝、抗血小板、输血以及外科治疗。
Current therapies for arterial ischemic stroke include thrombolytic, antithrombotic and antiplatelet agents, blood transfusion and surgery.
方法回顾性分析58例70岁以上老年pte患者的临床表现、诊断方法及溶栓、抗凝治疗的疗效。
Methods the clinical findings, diagnostic techniques, effects of thrombolytic therapy and anti-coagulation, in 58 over 70-year-old patients with PTE were analyzed retrospectively.
采用降颅压、扩容、抗凝及溶栓等治疗，10例痊愈，4例好转，1例死亡，1例自动出院。
After treatment by decreasing intracranial pressure, anticoagulation or thrombolysis, 10 cases recovered, 4 cases were better, 1 case died, 1 case gave up.
溶栓与抗凝疗法是治疗深静脉血栓的有效手段之一。
Anticoagulatic therapy and thrombolytic therapy are effective managements for acute cases of deep veins thrombosis and pulmary embolism.
结果关于抗凝治疗共检索到1篇系统评价、3篇随机对照试验及8篇前瞻性队列研究；关于溶栓治疗共检索到2篇系统评价和1篇临床对照试验。
Results We found 1 systematic review, 3 RCTs and 8 prospective cohort studies about anticoagulation therapy and 2 SRs and 1 CCT about thrombolysis therapy.
术后标准溶栓和抗凝治疗，随访有无咳嗽、胸痛、呼吸困难、晕厥等肺动脉栓塞症状；
The standard dissolves to bolt and the anti-cruor treatment, with visit whether have the symptom of pulmonary embolism, including cough, chest pain, dyspnea, etc.
指南还评价了IF-DVT的处理与初始及长期抗凝治疗，以及全身及导管直接溶栓。
The guidelines also review the management of IF-DVT and initial and long-term anticoagulant therapy, as well as systemic and catheter directed thrombolytics.
主要急救手段为对症治疗、抗凝、溶栓，必要时手术治疗。
The principal emergent medical treatments include the symptomatic treatment, anticoagulation, thrombolysis and operation.
结论DVT是射频消融术后少见并发症，发生率0.29%，下腔静脉滤器置入、溶栓、抗凝等早期综合治疗效果好。
Conclusions DVT is a rare complication after RFCA, with an incidence of 0.29%. Early and integrative treatment including filter-implanting, thrombolysis and anticoagulation has a good effect on DVT.
两组病人均经患肢行抗凝、溶栓等治疗。
Two groups received anticoagulation and thrombolysis via limbs involving DVT.
经溶栓抗凝治疗后，比对原有心电图上述项目皆发生了动态变化过程。
Compared with the original electrocardiograms, the dynamic changes in the above items occurred after the patients accepted thrombolytic and anticoagulant therapy.
目前对该病的治疗主要采取溶栓和抗凝，而影响肺动脉内血栓溶解的各因素成为疗效的关键。
At present, the treatment of the disease mainly taken thrombolysis and anticoagulation, and the effects of pulmonary thrombolytic efficacy of the factors become critical.
结果：116例病人经抗凝、溶栓治疗一周的复查、超声示血栓段静脉管腔缩小血流通畅，血栓再通。
Results:Color Doppler showed that the venous lumen decreased and the blood resumed to flow smoothly after one-week anticoagulant therapy and thrombolytic therapy.
结论对于DVT应进行早期溶栓、抗凝预防，疗效显著、安全。
Conclusion It is safe and effective to prevent DVT by giving early anti-coagulation and thrombolytic th...
结果：抗凝、溶栓治疗的患者住院期间有症状肺栓塞的发生率为2.86%（3/105），出院后随访无肺栓塞发生。
Results:The incidence of PE in patients treated with anticoagulation and thrombolysis alone during hospitalization was 2.86% (3/105), while no patients suffered from PE after discharge from hospital.
结果：抗凝、溶栓治疗的患者住院期间有症状肺栓塞的发生率为2.86%（3/105），出院后随访无肺栓塞发生。
Results:The incidence of PE in patients treated with anticoagulation and thrombolysis alone during hospitalization was 2.86% (3/105), while no patients suffered from PE after discharge from hospital.
应用推荐